Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|July 10, 2010
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1Steve Schoonooghe, Ingrid Burvenich, Liesbet Vervoort, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma modelIngrid Burvenich, Steve Schoonooghe, Bart Cornelissen, et al.Nuclear Medicine and Biology|November 26, 2008
In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptorPeter B M Blanckaert, Ingrid Burvenich, Leonie Wyffels, et al.Nuclear Medicine Communications|January 20, 2005
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factorBart Cornelissen, Veerle Kersemans, Ingrid Burvenich, et al.Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.Molecular Cancer Therapeutics|December 17, 2008
Monoclonal antibody 14C5 targets integrin alphavbeta5Ingrid Burvenich, Steve Schoonooghe, Liesbet Vervoort, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivoChristophe M M Lahorte, Klaus Bacher, Ingrid Burvenich, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
New strategies in polypeptide and antibody synthesis: an overviewNico Mertens, Filip Devos, Jannick Leoen, et al.Pageof 1